novo nordisk semaglutide copycat risk settles lawsuits over versions of Wegovy, Ozempic It's been a brutal week

[47] Melano I, Kuo LL, Lo YC, Sung PW, Tien N, Su WC

The predominantly female sample with obesity-range mean body mass index further limits applicability to smokers broadly

Diabetic retinopathy: Rapid improvements in glycaemic control as may occur with potent glucose-lowering agents have been associated with worsening of diabetic retinopathy in some patients

They are medications that need to be rightly prescribed by a doctor who is experienced in the management of insulin resistance and type 2 diabetes. Wegovy and Saxenda have been approved by the TGA for weight management in people with obesity or those considered overweight with at least one weight-related comorbidity

Glossy Finish: Adds shine without stickiness